Adheron Therapeutics' Acquisition

Adheron Therapeutics was acquired by Roche Holding on October 09, 2015.

Adheron Therapeutics, formerly Synovex, is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases. The target is Cadherin 11, a …

Articles about Adheron Therapeutics' Acquisition: